The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and-independent mechanisms - Natarajan, K; Bhullar, J; Shukla, S (Biochem Pharmacol, 2013)
et al.